Title:
HETEROARYL DERIVATIVE COMPOUND AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/211238
Kind Code:
A1
Abstract:
The present invention relates to a heteroaryl derivative and use thereof. The heteroaryl derivative of the present invention exhibits excellent inhibitory activity against EGFR, and thus is useful as a therapeutic agent for EGFR-related diseases.
Inventors:
LEE YOUN HO (KR)
PYUN YUMI (KR)
DO WOO MI (KR)
SON JUNGBEOM (KR)
KIM NAMDOO (KR)
KIM SUNGHWAN (KR)
KIM DAEKWON (KR)
PYUN YUMI (KR)
DO WOO MI (KR)
SON JUNGBEOM (KR)
KIM NAMDOO (KR)
KIM SUNGHWAN (KR)
KIM DAEKWON (KR)
Application Number:
PCT/KR2023/005855
Publication Date:
November 02, 2023
Filing Date:
April 28, 2023
Export Citation:
Assignee:
VORONOI INC (KR)
International Classes:
C07D471/04; A61K31/506; A61K31/519; A61K31/5377; A61K31/541; A61P35/00; C07D401/14; C07D487/04
Domestic Patent References:
| WO2021168074A1 | 2021-08-26 | |||
| WO2014210354A1 | 2014-12-31 |
Foreign References:
| KR20110026485A | 2011-03-15 | |||
| KR20150087850A | 2015-07-30 |
Other References:
EMILY J. HANAN, CHARLES EIGENBROT, MARIAN C BRYAN, DANIEL J BURDICK, BRYAN K CHAN, YUAN CHEN, JENNAFER DOTSON, ROBERT A HEALD, PHI: "Discovery of Selective and Noncovalent Diaminopyrimidine-Based Inhibitors of Epidermal Growth Factor Receptor Containing the T790M Resistance Mutation", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, vol. 57, no. 23, 11 December 2014 (2014-12-11), pages 10176 - 10191, XP055201841, ISSN: 00222623, DOI: 10.1021/jm501578n
Attorney, Agent or Firm:
KIM, Kyeongkyo et al. (KR)
Download PDF: